Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10355	Companies
215499	Keywords
145320	Articles
114165	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 01/28/2026 at 07:30, 3 months 9 days ago

Biophytis enters strategic agreement in Asia and secures $20 million for launch of Phase 3 trial in sarcopenia
Biophytis announces strategic agreement in Asia and secures $20 million for Phase 3 trial in sarcopenia, including creation of joint venture in Hong Kong and financing over 3 years

Biophytis Joint Venture Phase 3 Trial Sarcopenia Strategic Agreement
BRIEF

published on 01/12/2026 at 09:05, 3 months 25 days ago

Biophytis to Engage in Major Healthcare and Investment Events

Biophytis BIOMED Forum Longevity Therapies Healthcare Investment JP Morgan Healthcare
REGULATED PRESS RELEASE

published on 01/12/2026 at 09:00, 3 months 25 days ago

Biophytis to Participate in the JP Morgan Healthcare Conference and the Biomed Forum
Biophytis announces participation in JP Morgan Healthcare Conference and Biomed Forum in January 2026, presenting latest operational and clinical progress

Biophytis BIOMED Forum Age-related Diseases JP Morgan Healthcare Conference Transformative Therapies
PRESS RELEASE

published on 01/12/2026 at 08:59, 3 months 25 days ago

Biophytis to Participate in the JP Morgan Healthcare Conference and the Biomed Forum
Biophytis to participate in JP Morgan Healthcare Conference and Biomed Forum to engage with global financial and pharmaceutical communities for 2026 outlook

Biophytis BIOMED Forum Healthcare Conference JP Morgan 2026
BRIEF

published on 11/13/2025 at 18:35, 5 months 23 days ago

Results of Biophytis' General Meeting Held on November 13, 2025

Financial Statements Biophytis Shareholder Approval General Meeting Thérapies
REGULATED PRESS RELEASE

published on 11/13/2025 at 18:30, 5 months 23 days ago

RESULTS OF THE COMBINED GENERAL MEETING ON NOVEMBER 13, 2025
Biophytis SA announces the approval of all resolutions at the combined general meeting held on November 13, 2025, impacting longevity therapies development. Shareholder mobilization led to a 31% quorum

Longevity Therapies Combined General Meeting Biophytis SA Shareholder Mobilization Approval Of Resolutions
BRIEF

published on 10/30/2025 at 23:05, 6 months 7 days ago

Biophytis Announces Strategic Partnerships and Financial Results for H1 2025

Financial Results Strategic Partnerships Obesity Treatment Sarcopenia Clinical Trial Biophytis Expansion
REGULATED PRESS RELEASE

published on 10/30/2025 at 23:00, 6 months 7 days ago

Biophytis Reports First-Half 2025 Results and Provides Strategic Update
Biophytis reports first-half 2025 financial results and strategic update, including milestones in sarcopenia and obesity, highlighting expansion plans and financial elements

Financial Results Biophytis Sarcopenia Strategic Update Obesity
PRESS RELEASE

published on 10/30/2025 at 22:59, 6 months 7 days ago

Biophytis Reports First-Half 2025 Results and Provides Strategic Update
Biophytis reports financial results for the first half of 2025, strategic update, and key achievements in sarcopenia and obesity. Plans for Phase 2 and Phase 3 studies outlined with focus on sustaining growth and value creation

Financial Results Biophytis Sarcopenia Strategic Update Obesity
BRIEF

published on 10/13/2025 at 07:05, 6 months 24 days ago

Biophytis and Asian Investors to Launch Phase 3 Sarcopenia Trial

Biophytis Phase 3 Trial Sarcopenia BIO101 Asian Investors

Accesswire

Published on 05/06/2026 at 23:30, 1 hour 36 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 2 hours 1 minute ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 2 hours 6 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 2 hours 56 minutes ago

Banyan Gold Announces Closing of $46.5 Million Private Placement
Published on 05/06/2026 at 22:05, 3 hours 1 minute ago

Pivotree Announces Resignation of Board Director Patrick Meneley

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 00:47, 19 minutes ago

Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 22 minutes ago

EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 4 hours 34 minutes ago

EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 4 hours 44 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 5 hours 48 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/06/2026 at 18:00, 7 hours 5 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 7 hours 6 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 17:45, 7 hours 21 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30
Published on 05/06/2026 at 17:45, 7 hours 21 minutes ago

Declaration of voting rights at the end of April 2026
Published on 05/06/2026 at 17:45, 7 hours 21 minutes ago

Accor - Information regarding availability and consultation of preparatory documents - Shareholders' Meeting of May 27, 2026

View all LES ECHOS COMFI WIRE